Hospira A Pfizer Company
Hospira A Pfizer Company has 4 FDA recalls, 0 inspections, 0 510(k) clearances and 0 compliance actions on record.
- Latest recall
- D-1047-2017 · Class II · Jun 15, 2017
Newer recall under related name Pfizer: Sep 29, 2026, D-0052-2027.
Reviewing Hospira A Pfizer Company as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Hospira A Pfizer Company yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 4 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 0 | Nov 13, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1047-2017 | Class II | 8.4% Sodium Bicarbonate Inj., USP 50 mL Single-dose, 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL), Rx… | Jun 15, 2017 |
| D-1049-2017 | Class II | Neut Sodium Bicarbonate 4% (2.4 mEq) Additive Solution 5 mL , a.) Single-dose vial (NDC… | Jun 15, 2017 |
| D-1046-2017 | Class II | Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15 mL… | Jun 15, 2017 |
| D-1048-2017 | Class II | Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For… | Jun 15, 2017 |
Need more than this page shows? Ask about Hospira A Pfizer Company in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.